Nucleolar exit of RNF8 and BRCA1 in response to DNA damage
Marta Guerra‐Rebollo(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Timothy M. Thomson(Universidad Peruana Cayetano Heredia), Fernando Lopitz‐Otsoa(CIC bioGUNE), Francesca Mateo(Institut d'Investigació Biomédica de Bellvitge), Vanessa Plans(Institut de Biologia Molecular de Barcelona), Kristin Franke(Humboldt-Universität zu Berlin), Manuel S. Rodríguez(Centre National de la Recherche Scientifique), Michael S.Y. Huen(University of Hong Kong)
Cited by 25
Related Papers
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
|Journal of Biological Chemistry|2001|737
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
|Journal of Clinical Investigation|2012|462
Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks
|Genome Research|2016|278
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
|Proceedings of the National Academy of Sciences|1984|273
Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis
|Nature Communications|2017|162